GT Biopharma
GTBP
GTBP
20 hedge funds and large institutions have $220K invested in GT Biopharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
99% less capital invested
Capital invested by funds: $29.3M → $220K (-$29.1M)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$45.1K | |
| 2 | +$18.3K | |
| 3 | +$131 | |
| 4 |
GIA
GHP Investment Advisors
Denver,
Colorado
|
+$71 |
| 5 |
FRA
Front Row Advisors
Tiburon,
California
|
+$2 |
Top Sellers
| 1 | -$29M | |
| 2 | -$32K | |
| 3 | -$5.24K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.3K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$17 |
